Jeff Yass’s Helus Pharma HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$887K Buy
72,152
+46,036
+176% +$481K ﹤0.01% 8269
2026
Q2
$173K Sell
26,116
-121,809
-82% -$609K ﹤0.01% 12085
2026
Q1
$710K Sell
147,925
-152,305
-51% -$985K ﹤0.01% 8782
2025
Q4
$2.46M Buy
300,230
+26,435
+10% +$170K ﹤0.01% 5222
2025
Q3
$1.61M Buy
273,795
+248,887
+999% +$1.76M ﹤0.01% 6247
2025
Q2
$209K Buy
+24,908
New +$181K ﹤0.01% 11120
2025
Q1
– Sell
-82,859
Closed -$717K – 12627
2024
Q4
$731K Buy
+82,859
New +$841K ﹤0.01% 7723
2023
Q1
– Sell
-282
Closed -$3.18K – 12687
2022
Q4
$3.18K Buy
+282
New +$4.65K ﹤0.01% 12097
2022
Q1
– Sell
-1,288
Closed -$59K – 13123
2021
Q4
$59K Buy
1,288
+992
+335% +$62.8K ﹤0.01% 12453
2021
Q3
$25K Buy
+296
New +$25.9K ﹤0.01% 12509

Other funds holding HELP

Jeff Yass's HELP Position: Q3 2026 in Review

Jeff Yass increased its Helus Pharma (HELP) stake by 176% in Q3 2026, buying an estimated $481K and bringing the position to 72,152 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #8269.

Jeff Yass first reported a position in HELP in Q3 2021 and has held it in 10 quarters since. The position peaked at $2.46M in Q4 2025. 108 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Jeff Yass held 72,152 shares of Helus Pharma worth $887K as of Q3 2026.
  • Jeff Yass bought 46,036 Helus Pharma shares in Q3 2026, an estimated $481K.
  • Helus Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8269 holding.
  • Jeff Yass first reported a position in Helus Pharma in Q3 2021 and has held it in 10 quarters since.
  • Jeff Yass's Helus Pharma position peaked at $2.46M in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Helus Pharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.